LANGUAGE
KOREAN
ENGLISH
LOCATION
COMPANY
R&D
R&D Institute
GMP Center
Clinical Development Status
Publications
PRODUCTS
1st Generation
Overview
CARTISTEM
®
PNEUMOSTEM
®
2nd Generation
Overview
SMUP-IA-01
SMUP-IV-01
R&D Inquiries
BUSINESS
CDMO
Quality System
CDMO Service
Quality Control
Global CDMO
CDMO Inquiries
CELLTREE Cord Blood Bank
MOVITA Nutritional Supplements
IR
Stock Information
Disclosure
Financial Information
IR Inquiries
PR
MEDIPOST on Media
Corporate Brochure
CONTACT US
Customer Center
R&D Inquiries
CDMO Inquiries
IR Inquiries
Search Results
Stem cell cartilage differentiation technology Singapore patent
2014/03/18
Clinical thesis for lung treatment ‘PNEUMOSTEM’ published in international acade…
2014/02/10
Football Manager Guus Hiddink, receives arthritis surgery with MEDIPOST’s stem c…
2014/01/09
Designated ‘Stem Cell Hair Growth Solution’ research institution by Ministry Com…
2013/12/20
Signed license for ‘CARTISTEM’ in India
2013/12/16
Strengthening marketing of ‘CARTISTEM’ by participating in numerous overseas aca…
2013/12/09
Lung Treatment Medicine ‘PNEUMOSTEM’ designated Orphan Drug by US FDA
2013/12/05
Core technology of the Alzheimer’s dementia treatment patented in US
2013/10/24
MEDIPOST recognized as ‘investible’ stem cell firm
2013/10/14
Stem cell dementia treatment 2a clinically approved
2013/09/11
‘CARTISTEM’, intensive report on Chicago’s WGN-TV
2013/08/29
Consecutive international patents in dementia treatment
2013/08/23
Previous
1
…
10
11
12
13
14
Next
Menu